KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $24.1 million.

  • Neogenomics' Other Operating Expenses rose 9.57% to $24.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $119.8 million, marking a year-over-year increase of 3469.5%. This contributed to the annual value of $119.8 million for FY2025, which is 4147.33% up from last year.
  • Per Neogenomics' latest filing, its Other Operating Expenses stood at $24.1 million for Q4 2025, which was up 9.57% from $28.9 million recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Other Operating Expenses registered a high of $44.1 million during Q2 2025, and its lowest value of $13.7 million during Q1 2021.
  • Its 5-year average for Other Operating Expenses is $20.5 million, with a median of $17.8 million in 2023.
  • Per our database at Business Quant, Neogenomics' Other Operating Expenses tumbled by 88.83% in 2022 and then surged by 8998.32% in 2025.
  • Over the past 5 years, Neogenomics' Other Operating Expenses (Quarter) stood at $15.9 million in 2021, then rose by 7.7% to $17.1 million in 2022, then rose by 5.43% to $18.1 million in 2023, then skyrocketed by 33.06% to $24.0 million in 2024, then increased by 0.1% to $24.1 million in 2025.
  • Its last three reported values are $24.1 million in Q4 2025, $28.9 million for Q3 2025, and $44.1 million during Q2 2025.